[{"id":"f752f9ef-2f89-4912-9fbf-45235ee48f90","acronym":"","url":"https://clinicaltrials.gov/study/NCT05117658","created_at":"2021-11-11T12:53:34.542Z","updated_at":"2024-07-02T16:36:06.083Z","phase":"Phase 2","brief_title":"Study of HA121-28 in Patients With Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT05117658","lead_sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","biomarkers":" RET","pipe":" | ","alterations":" RET fusion","tags":["RET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RET fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HA121-28"],"overall_status":"Recruiting","enrollment":" Enrollment 83","initiation":"Initiation: 02/18/2022","start_date":" 02/18/2022","primary_txt":" Primary completion: 10/01/2023","primary_completion_date":" 10/01/2023","study_txt":" Completion: 10/01/2023","study_completion_date":" 10/01/2023","last_update_posted":"2022-08-04"}]